EP2882770 - COMBINATIONS WITH A BACKBONE-CYCLIZED PEPTIDE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.04.2018 Database last updated on 24.07.2024 | |
Former | The patent has been granted Status updated on 28.04.2017 | ||
Former | Grant of patent is intended Status updated on 20.12.2016 | ||
Former | Examination is in progress Status updated on 31.10.2016 | Most recent event Tooltip | 21.09.2018 | Lapse of the patent in a contracting state New state(s): MT | published on 24.10.2018 [2018/43] | Applicant(s) | For all designated states Polyphor AG Hegenheimermattweg 125 4123 Allschwil / CH | [2015/25] | Inventor(s) | 01 /
DALE, Glenn E. C.F. Meyer-Strasse 10 4059 Basel / CH | 02 /
OBRECHT, Daniel Im Eichacker 21 4112 Bättwil / CH | 03 /
BERNARDINI, Francesca 6, Rue des Peupliers 68220 Hésingue / FR | [2015/25] | Representative(s) | Braun, André jr., et al Braunpat Braun Eder AG Reussstrasse 22 4054 Basel / CH | [2017/22] |
Former [2015/25] | Braun, André jr., et al Braunpat Braun Eder AG Reussstrasse 22 4054 Basel / CH | Application number, filing date | 13745432.8 | 07.08.2013 | [2017/22] | WO2013EP66530 | Priority number, date | EP20120005744 | 08.08.2012 Original published format: EP 12005744 | [2015/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014023757 | Date: | 13.02.2014 | Language: | EN | [2014/07] | Type: | A1 Application with search report | No.: | EP2882770 | Date: | 17.06.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.02.2014 takes the place of the publication of the European patent application. | [2015/25] | Type: | B1 Patent specification | No.: | EP2882770 | Date: | 31.05.2017 | Language: | EN | [2017/22] | Search report(s) | International search report - published on: | EP | 13.02.2014 | Classification | IPC: | C07K7/64, A61K38/12 | [2015/25] | CPC: |
A61K38/12 (EP,KR,US);
C07K7/64 (EP,KR,US);
A61K31/65 (EP,KR,US);
A61K38/10 (EP,KR,US);
A61P31/04 (EP,KR);
A61P43/00 (EP);
C07K7/08 (KR,US);
A61K2300/00 (KR);
A61K38/00 (KR);
| C-Set: |
A61K31/65, A61K2300/00 (US,EP);
A61K38/12, A61K2300/00 (EP,US) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/25] | Extension states | BA | 09.03.2015 | ME | 09.03.2015 | Title | German: | KOMBINATIONEN MIT EINEM BACKBONE-CYCLIERTEN PEPTID | [2015/25] | English: | COMBINATIONS WITH A BACKBONE-CYCLIZED PEPTIDE | [2015/25] | French: | COMBINAISONS AVEC UN PEPTIDE À SQUELETTE CYCLISÉ | [2015/25] | Entry into regional phase | 09.03.2015 | National basic fee paid | 09.03.2015 | Designation fee(s) paid | 09.03.2015 | Examination fee paid | Examination procedure | 09.03.2015 | Examination requested [2015/25] | 05.10.2015 | Amendment by applicant (claims and/or description) | 21.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 27.10.2016 | Reply to a communication from the examining division | 21.12.2016 | Communication of intention to grant the patent | 20.04.2017 | Fee for grant paid | 20.04.2017 | Fee for publishing/printing paid | 20.04.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.06.2016 | Opposition(s) | 01.03.2018 | No opposition filed within time limit [2018/19] | Fees paid | Renewal fee | 31.08.2015 | Renewal fee patent year 03 | 31.08.2016 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | FI | 31.05.2017 | MC | 31.05.2017 | SM | 31.05.2017 | MT | 07.08.2017 | NO | 31.08.2017 | IS | 30.09.2017 | [2018/43] |
Former [2018/18] | FI | 31.05.2017 | |
MC | 31.05.2017 | ||
SM | 31.05.2017 | ||
NO | 31.08.2017 | ||
IS | 30.09.2017 | ||
Former [2018/13] | FI | 31.05.2017 | |
SM | 31.05.2017 | ||
NO | 31.08.2017 | ||
IS | 30.09.2017 | ||
Former [2017/50] | FI | 31.05.2017 | |
NO | 31.08.2017 | ||
IS | 30.09.2017 | Cited in | International search | [A]WO2007079597 (POLYPHOR LTD [CH], et al) [A] 1-12 * whole doc, in particular claims 16-29 and p.78, lines 17-20 *; | [A] - ENTENZA J M ET AL, "Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, ELSEVIER SCIENCE, AMSTERDAM, NL, vol. 34, no. 1, doi:10.1016/J.IJANTIMICAG.2008.11.006, ISSN 0924-8579, (20090701), pages 8.e1 - 8.e9, (20090121), XP026127707 [A] 1-12 * the whole document * DOI: http://dx.doi.org/10.1016/j.ijantimicag.2008.11.006 | [A] - PAGE M G ET AL, "Prospects for the next anti-Pseudomonas drug", CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 9, no. 5, doi:10.1016/J.COPH.2009.08.006, ISSN 1471-4892, (20091001), pages 558 - 565, (20090912), XP026665547 [A] 1-12 * the whole document * DOI: http://dx.doi.org/10.1016/j.coph.2009.08.006 | by applicant | WO02070547 | WO2004018503 | WO2007079605 | WO2007079597 | - H. BREITHAUPT, NAT. BIOTECHNOL., (1999), vol. 17, pages 1165 - 1169 | - T. GANZ; R. I. LEHRER, MOL. MEDICINE TODAY, (1999), vol. 5, pages 292 - 297 | - R. M. EPAND; H. J. VOGEL, BIOCHIM. BIOPHYS. ACTA, (1999), vol. 1462, pages 11 - 28 | - 0. V. SHAMOVA; H. A. KORNEVA; R. I. LEHRER, FEBS LETT., (1993), vol. 327, pages 231 - 236 | - T. NAKAMURA; H. FURUNAKA; T. MIYATA; F. TOKUNAGA; T. MUTA; S. IWANAGA; M. NIWA; T. TAKAO; Y. SHIMONISHI; Y. J., BIOL. CHEM., (1988), vol. 263, pages 16709 - 16713 | - R. I. LEHRER; A. K. LICHTENSTEIN; T. GANZ, ANNU. REV. IMMUNOL., (1993), vol. 11, pages 105 - 128 | - A. TOSSI; L. SANDRI; A. GIANGASPERO, BIOPOLYMERS, (2000), vol. 55, pages 4 - 30 | - H. W. HUANG, BIOCHEMISTRY, (2000), vol. 39, pages 8347 - 8352 | - M. WU; E. MAIER; R. BENZ; R. E. HANCOCK, BIOCHEMISTRY, (1999), vol. 38, pages 7235 - 7242 | - M. SCOCCHI; A. TOSSI; R. GENNARO, CELL. MOL. SCI., (2011), vol. 68, pages 2317 - 2330 | - N. SITARAM; R. NAGARAJ, BIOCHIM. BIOPHYS. ACTA, (1999), vol. 1462, pages 29 - 54 | - A. AUMELAS; M. MANGONI; C. ROUMESTAND; L. CHICHE; E. DESPAUX; G. GRASSY; B. CALAS; A. CHAVANIEU, EUR. J. BIOCHEM., (1996), vol. 237, pages 575 - 583 | - R. L. FAHRNER; T. DIECKMANN; S. S. L. HARWIG; R. I. LEHRER; D. EISENBERG; J. FEIGON, J. CHEM. BIOL., (1996), vol. 3, pages 543 - 550 | - K. KAWANO; T. YONEYA; T. MIYATA; K. YOSHIKAWA; F. TOKUNAGA; Y. TERADA; S. J. IWANAGA, J. BIOL. CHEM., (1990), vol. 265, pages 15365 - 15367 | - L. H. KONDEJEWSKI; M. JELOKHANI-NIARAKI; S. W. FARMER; B. LIX; M. KAY; B. D. SYKES; R. E. HANCOCK; R. S. HODGES, J. BIOL. CHEM., (1999), vol. 274, pages 13181 - 13192 | - C. MCLNNESL.; H. KONDEJEWSKI; R. S. HODGES; B. D. SYKES, J. BIOL. CHEM., (2000), vol. 275, pages 14287 - 14294 | - D. OBRECHT; M. ALTORFER; J. A. ROBINSON, ADV. MED. CHEM., (1999), vol. 4, pages 1 - 68 | - J. A. ROBINSON, SYN. LETT., (2000), vol. 4, pages 429 - 441 | - L. JIANG; K. MOEHLE; B. DHANAPAL; D. OBRECHT; J. A. ROBINSON, HELV. CHIM. ACTA., (2000), vol. 83, pages 3097 - 3112 | - G. A. PANKEY, J. ANTIMICROB. CHEMOTHER., (2005), vol. 56, pages 470 - 480 | - Y. CAI; R. WANG; B. LIANG; N. BAI; Y. LIU, ANTIMICROB. AGENTS CHEMOTHER., (2011), vol. 55, pages 1162 - 1172 | - D. YAHAV; A. LADOR; M. PAUL; L. LEIBOVICI, J. ANTIMICROB. CHEMOTHER., (2011), vol. 66, pages 1963 - 1971 | - E. TASINA; A. B. HAIDICH; S. KOKKALI; M. ARVANITIDOU, LANCET INFECT. DIS., (2011), vol. 11, pages 834 - 844 | - E. JAWETZ, ANTIMICROB. AGENTS CHEMOTHER., (1967), pages 203 - 209 | - T.-C. CHOU; P. TALALAY, ADV. ENZYME REGUL., (1984), vol. 22, pages 27 - 55 | - J. M. T. HAMILTON-MILLER, J. ANTIMICROB. CHEMOTHER., (1985), vol. 15, pages 655 - 657 | - G. M. ELIOPOULOS, R. C.; MOELLERING JR., Antibiotics in laboratory medicine, THE WILLIAM & WILKINS CO., (1991), pages 432 - 492 | - H. 0. HALLENDER ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1982), vol. 22, pages 743 - 752 | - M. J. HALL ET AL., J. ANTIMICROB. CHEMOTHER., (1983), vol. 11, pages 427 - 433 | - R. C. LI ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1993), vol. 37, pages 523 - 531 | - CHR. C. SANDERS ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1993), vol. 37, pages 260 - 264 | - J. M. ENTENZA; P. MORREILLON, INT. J. ANTIMICROB. AGENTS, (2009), vol. 34, pages 8.E1 - 8.E9 |